Conference Co-Chairs:

Beth Janeway Hallyburton

Assistant General Counsel and Head, US Government Investigations
GlaxoSmithKline (Durham, NC)

Daniel J. Moynihan

Global Compliance Officer - Life Science
MilliporeSigma, A business of Merck KGaA (Boston, MA)

Speakers:

S. Joy Dowdle

Partner
Paul Hastings LLP (Houston, TX)

Irina Dragulev

Assistant General Counsel
Pfizer Inc. (New York, NY)

Michael Dusseau

Vice President, Compliance Operations
Allergan plc (Parsippany, NJ)

James A. Garrett

Chief Risk and Compliance Officer and Leader, Global Risk & Integrity
NuVasive, Inc. (San Diego, CA)

Beth Janeway Hallyburton

Assistant General Counsel and Head, US Government Investigations
GlaxoSmithKline (Durham, NC)

Markus Hartmann

Vice President & North American General Counsel
Sandoz (Princeton, NJ)

James P. Loonam

Deputy Chief, Business and Securities Fraud Section
United States Attorney’s Office, E.D.N.Y.

Barry McCoy

Executive Director, Lead of Anti- Corruption Program
Merck & Co., Inc. (Philadelphia, PA)

Sandra Moser

Principal Deputy Chief
U.S. Department of Justice, Criminal Division, Fraud Section

Daniel J. Moynihan

Global Compliance Officer - Life Science
MilliporeSigma, A business of Merck KGaA (Boston, MA)

Michael C. Pacella

Vice President, Global Anti-Corruption & Investigations Counsel
Zimmer Biomet (Washington, DC)

Suzanne C. Seferian

Health Care Compliance Officer
Johnson & Johnson (Titusville, NJ)

Peter Schutzel

Division Counsel, Anti-Corruption & Global Healthcare Compliance
Abbott (Chicago, IL)

Keir Strauss

Assistant General Counsel & Global Privacy Officer
INC Research (Durham, NC)

Avi Spira

Vice President & Chief Compliance Officer
Cantel Medical Corp. (Little Falls, NJ)

Aaron Tidman

Anti-Corruption Counsel
Gilead Sciences Inc. (San Francisco, CA)

Hank Bond Walther

Partner
Jones Day (Washington, DC)